Pulsed Field Ablation (PFA) emerges as a significant advancement in treating Atrial Fibrillation (AFib), an increasingly prevalent heart rhythm disorder associated with stroke risk. PFA utilizes controlled electric fields via irreversible electroporation for targeted cardiac tissue ablation, potentially minimizing damage to surrounding structures compared to traditional thermal methods like radiofrequency ablation. The technology fuels a competitive market, with major medtech companies launching distinct PFA systems comprising specialized catheters, generators, and advanced mapping software. Manufacturing partners are integral, addressing demands identified by Cirtec for smart catheters with integrated electronics, high-voltage capabilities, microcatheters, steerable shafts, and cost-effective production solutions, alongside providing essential components and assembly services.

Read more at: mpo-mag.com